Standout Papers

Mepolizumab Treatment in Patients with Severe E... 2002 2026 2010 2018 1.5k
  1. Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma (2014)
    Héctor Ortega, Mark C. Liu et al. New England Journal of Medicine
  2. Pulmonary Arterial Hypertension in France (2006)
    Marc Humbert, Olivier Sitbon et al. American Journal of Respiratory and Critical Care Medicine
  3. Treatment of Pulmonary Arterial Hypertension (2004)
    Marc Humbert, Olivier Sitbon et al. New England Journal of Medicine
  4. Cellular and molecular pathobiology of pulmonary arterial hypertension (2004)
    Marc Humbert, Nicholas W. Morrell et al. Journal of the American College of Cardiology
  5. Long-term intravenous epoprostenol infusion in primary pulmonary hypertension (2002)
    Olivier Sitbon, Marc Humbert et al. Journal of the American College of Cardiology
  6. Riociguat for the Treatment of Pulmonary Arterial Hypertension (2013)
    Hossein Ardeschir Ghofrani, Nazzareno Galiè et al. New England Journal of Medicine
  7. Benefits of omalizumab as add‐on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE (2004)
    Marc Humbert, Richard Beasley et al. Allergy
  8. Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives (2018)
    Marc Humbert, Christophe Guignabert et al. European Respiratory Journal
  9. Long-Term Response to Calcium Channel Blockers in Idiopathic Pulmonary Arterial Hypertension (2005)
    Olivier Sitbon, Marc Humbert et al. Circulation
  10. Inflammation and Immunity in the Pathogenesis of Pulmonary Arterial Hypertension (2014)
    Marlene Rabinovitch, Christophe Guignabert et al. Circulation Research
  11. Treatable traits: toward precision medicine of chronic airway diseases (2016)
    Àlvar Agustí, Elisabeth H. Bel et al. European Respiratory Journal
  12. Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension. (1995)
    Marc Humbert, Gianpaola Monti et al. American Journal of Respiratory and Critical Care Medicine
  13. A global view of pulmonary hypertension (2016)
    Marius M. Hoeper, Marc Humbert et al. The Lancet Respiratory Medicine
  14. Inflammation, Growth Factors, and Pulmonary Vascular Remodeling (2009)
    Paul M. Hassoun, Luc Mouthon et al. Journal of the American College of Cardiology
  15. Pathologic assessment of vasculopathies in pulmonary hypertension (2004)
    Giuseppe G. Pietra, Frédérique Capron et al. Journal of the American College of Cardiology
  16. Early detection of pulmonary arterial hypertension in systemic sclerosis: A French nationwide prospective multicenter study (2005)
    É. Hachulla, Virginie Gressin et al. Arthritis & Rheumatism
  17. Clinical and Molecular Genetic Features of Pulmonary Hypertension in Patients with Hereditary Hemorrhagic Telangiectasia (2001)
    Richard C. Trembath, Jennifer R. Thomson et al. New England Journal of Medicine
  18. Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension (2010)
    Marc Humbert, Olivier Sitbon et al. European Respiratory Journal
  19. Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension (2017)
    Athénaïs Boucly, Jason Weatherald et al. European Respiratory Journal
  20. Endothelial-to-Mesenchymal Transition in Pulmonary Hypertension (2015)
    Benoît Ranchoux, Fabrice Antigny et al. Circulation
  21. Pulmonary Arterial Hypertension (2013)
    Michael D. McGoon, Raymond L. Benza et al. Journal of the American College of Cardiology
  22. Genetics and Genomics of Pulmonary Arterial Hypertension (2013)
    Florent Soubrier, Wendy K. Chung et al. Journal of the American College of Cardiology
  23. Epidemiology and treatment of pulmonary arterial hypertension (2017)
    Edmund Lau, Eleni Giannoulatou et al. Nature Reviews Cardiology
  24. Sotatercept for the Treatment of Pulmonary Arterial Hypertension (2021)
    Marc Humbert, Vallerie V. McLaughlin et al. New England Journal of Medicine
  25. Post-acute COVID-19 syndrome (2022)
    David Montani, Laurent Savale et al. European Respiratory Review
  26. Pulmonary hypertension (2024)
    Ana Olga Mocumbi, Marc Humbert et al. Nature Reviews Disease Primers
  27. Pathology and pathobiology of pulmonary hypertension: current insights and future directions (2024)
    Christophe Guignabert, Jurjan Aman et al. European Respiratory Journal

Immediate Impact

6 by Nobel laureates 11 from Science/Nature 135 standout
Sub-graph 1 of 16

Citing Papers

TGF-β signaling in health and disease
2023 Standout
Top-down design of protein architectures with reinforcement learning
2023 StandoutScienceNobel
5 intermediate papers

Works of Marc Humbert being referenced

Widening the landscape of heritable pulmonary hypertension mutations in paediatric and adult cases
2018
Current Insights on the Pathogenesis of Pulmonary Arterial Hypertension
2005
and 8 more

Author Peers

Author Last Decade Papers Cites
Marc Humbert 46488 21000 12182 917 58.9k
Gérald Simonneau 46462 29459 4067 473 56.8k
Hossein Ardeschir Ghofrani 26892 17252 3947 554 33.5k
Rubin M. Tuder 20156 5311 4925 322 32.3k
Murray F. Brennan 42545 8918 4353 951 79.5k
Børge G. Nordestgaard 8545 16415 8277 936 63.7k
Amir Lerman 8099 26356 7098 868 49.5k
David Cunningham 30035 2574 2012 1.2k 76.0k
Thomas F. Lüscher 6152 27493 16237 1.1k 61.0k
Andreas M. Zeiher 5067 17574 10443 548 68.1k
Magdi H. Yacoub 7715 16276 3312 973 35.5k

All Works

Loading papers...

Rankless by CCL
2026